American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
High-risk groups for pancreatic ductal adenocarcinoma include people with inherited predisposition, people with pancreatic cystic lesions, and people older than 50 years with newly diagnosed type 2 diabetes.
“Here, we review groups at high risk for pancreatic ductal adenocarcinoma, including individuals with inherited predisposition and patients with pancreatic cystic lesions.”
From Early detection of pancreatic cancer (2020) · cites this paper as [21]
An incidental pancreatic cyst seen on MRI has a 10 in 100,000 chance of being a mucinous invasive malignancy and a 17 in 100,000 chance of being a ductal cancer.
“It is estimated that a cyst seen incidentally on MRI has a 10 in 100 000 chance of being a mucinous invasive malignancy, and a 17 in 100 000 chance of being a ductal cancer.21”
From Early detection of pancreatic cancer (2020) · cites this paper as [21]
The 5% lifetime-risk target group includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes, and individuals with mucinous cystic lesions of the pancreas.
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [21]
Guidelines recommend immediate surgical resection for any pancreatic lesion with high-risk stigmata and regular surveillance with interval imaging for all mucinous or indeterminate lesions.
“Guidelines recommend immediate surgical resection for any lesion with high-risk stigmata, and regular surveillance with interval imaging (MRI or endoscopic ultrasound) for all mucinous or indeterminate lesions.21,60”
From Early detection of pancreatic cancer (2020) · cites this paper as [21]
Surveillance protocols for pancreatic cysts typically recommend cross-sectional imaging once every 6 months in the first year and annually thereafter if no changes are detected.
“Surveillance protocols vary between the different guidelines, but typically recommend cross-sectional imaging once every 6 months in the first year, and annually thereafter if no changes are detected.”
From Early detection of pancreatic cancer (2020) · cites this paper as [21]
More frequent surveillance is advocated for larger pancreatic lesions or lesions with worrisome features.
“More frequent surveillance is advocated for larger lesions or lesions with worrisome features.21,60”
From Early detection of pancreatic cancer (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · see citing works
Scheiman, J. M., Hwang, J. H., & Moayyedi, P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.014 · Cited by 437 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
European evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas (2018) · Gut · doi:10.1136/gutjnl-2018-316027 · Cited by 1,417 · see citing works
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841 · see citing works
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482 · see citing works
Canto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414 · see citing works
Singhi, A. D., McGrath, K., Brand, R. E., Khalid, A., Zeh, H. J., Chennat, J. S., Fasanella, K. E., Papachristou, G. I., Slivka, A., Bartlett, D. L., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313586 · Cited by 405 · see citing works
Early detection of pancreatic cancer using DNA-based molecular approaches
Singhi, A. D., & Wood, L. D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00470-0 · Cited by 127 · see citing works
Fujikura, K., Hosoda, W., Felsenstein, M., Song, Q., Reiter, J. G., Zheng, L., Beleva Guthrie, V., Rincon, N., Dal Molin, M., Dudley, J., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321217 · Cited by 89 · see citing works
Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models
Liang, W., Tian, W., Wang, Y., Wang, P., Wang, Y., Zhang, H., Ruan, S., Shao, J., Zhang, X., Huang, D., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10273-4 · Cited by 51 · see citing works
Dbouk, M., Brewer Gutierrez, O. I., Lennon, A. M., Chuidian, M., Shin, E. J., Kamel, I. R., Fishman, E. K., He, J., Burkhart, R. A., Wolfgang, C. L., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.017 · Cited by 46 · see citing works
Pancreatic solid incidentalomas
Santo, E., & Bar-Yishay, I. (2017) · Endoscopic Ultrasound · doi:10.4103/eus.eus_72_17 · Cited by 26 · see citing works
Pancreatic Cysts—An Overview and Summary of Society Guidelines, 2021
Ayoub, F., Davis, A. M., & Chapman, C. G. (2021) · JAMA · doi:10.1001/jama.2020.18678 · Cited by 23 · see citing works
Liu, Y., Kaur, S., Huang, Y., Fahrmann, J. F., Rinaudo, J. A., Hanash, S. M., Batra, S. K., Singhi, A. D., Brand, R. E., Maitra, A., et al. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0161 · Cited by 17 · see citing works
- Authors
- Vege, S. S., Ziring, B., Jain, R., Moayyedi, P., Adams, M. A., Dorn, S. D., Dudley-Brown, S. L., Flamm, S. L., Gellad, Z. F., Gruss, C. B., Kosinski, L. R., Lim, J. K., Romero, Y., Rubenstein, J. H., Smalley, W. E., Sultan, S., Weinberg, D. S., & Yang, Y.-X.
- Affiliations
- Mayo Clinic (US)
- Thomas Jefferson University (US)
- Texas Digestive Disease Consultants (US)
- Hamilton Health Sciences (CA)
- McMaster University (CA)
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 148
- Issue
- 4
- Pages
- 819-822
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2016448153
- Cited by
- 1,138
- References
- 3
- Citations by year
- 2026: 89 · 2025: 95 · 2024: 110 · 2023: 117 · 2022: 96 · 2021: 108 · 2020: 114 · 2019: 92 · 2018: 116 · 2017: 101 · 2016: 74 · 2015: 25
- FWCI
- 46.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Yale University
- Vanderbilt University
- University of Pennsylvania
- Northwestern University
- University of Minnesota
- Johns Hopkins University
- School of Medicine, Vanderbilt University
- University of North Carolina at Chapel Hill
- Perelman School of Medicine, University of Pennsylvania
- Feinberg School of Medicine
- Medical School, University of Michigan
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Keywords
- pancreatic cysts, mucinous pancreatic cysts, pancreatic ductal adenocarcinoma, endoscopic ultrasound, fine needle aspiration cytology, magnetic resonance imaging, pancreatic surgery, dysplasia
- MeSH terms
- Adenocarcinoma, Gastroenterology, Humans, Pancreatic Cyst, Pancreatic Neoplasms, Societies, Medical, Risk Assessment, Disease Management, Carcinoma, Pancreatic Ductal, Incidental Findings, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
